15 August 2019
Interim Results
Interim results for the half year ended 30 June 2019…
Dividend Declaration
14 August 2019
Directorate Change
Interim Accounts 30th June 2019…
New corporate name for M&GPrudential at demerger…
Interim Management Statement for the six months ended 30 June 2019…
Calquence granted US Breakthrough Therapy Designation for chronic lymphocytic leukaemia…